Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)
Clinical trial NCT01539291 · TERMINATED
Trial details
- NCT number
- NCT01539291
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-03
- Primary completion
- 2018-05-21
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.